How MicroRNA and Transcription Factor Co-regulatory Networks Affect Osteosarcoma Cell Proliferation

Osteosarcomas (OS) are complex bone tumors with various genomic alterations. These alterations affect the expression and function of several genes due to drastic changes in the underlying gene regulatory network. However, we know little about critical gene regulators and their functional consequences on the pathogenesis of OS. Therefore, we aimed to determine microRNA and transcription factor (TF) co-regulatory networks in OS cell proliferation. Cell proliferation is an essential part in the pathogenesis of OS and deeper understanding of its regulation might help to identify potential therapeutic targets. Based on expression data of OS cell lines divided according to their proliferative activity, we obtained 12 proliferation-related microRNAs and corresponding target genes. Therewith, microRNA and TF co-regulatory networks were generated and analyzed regarding their structure and functional influence. We identified key co-regulators comprising the microRNAs miR-9-5p, miR-138, and miR-214 and the TFs SP1 and MYC in the derived networks. These regulators are implicated in NFKB- and RB1-signaling and focal adhesion processes based on their common or interacting target genes (e.g., CDK6, CTNNB1, E2F4, HES1, ITGA6, NFKB1, NOTCH1, and SIN3A). Thus, we proposed a model of OS cell proliferation which is primarily co-regulated through the interactions of the mentioned microRNA and TF combinations. This study illustrates the benefit of systems biological approaches in the analysis of complex diseases. We integrated experimental data with publicly available information to unravel the coordinated (post)-transcriptional control of microRNAs and TFs to identify potential therapeutic targets in OS. The resulting microRNA and TF co-regulatory networks are publicly available for further exploration to generate or evaluate own hypotheses of the pathogenesis of OS (http://www.complex-systems.uni-muenster.de/co_networks.html).

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[3]  Giovanni Vanni Frajese,et al.  miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.

[4]  Zhongming Zhao,et al.  Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma , 2012, PLoS Comput. Biol..

[5]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[6]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[7]  A. Hata,et al.  Regulation of MicroRNA Biogenesis: A miRiad of mechanisms , 2009, Cell Communication and Signaling.

[8]  R. Foisner,et al.  E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity , 2001, The Journal of cell biology.

[9]  Kevin B. Jones,et al.  miRNA signatures associate with pathogenesis and progression of osteosarcoma. , 2012, Cancer research.

[10]  Min Liu,et al.  MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase 7* , 2012, The Journal of Biological Chemistry.

[11]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[12]  P. Pu,et al.  MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN , 2010, BMC Cancer.

[13]  Daniel Rios,et al.  Ensembl 2011 , 2010, Nucleic Acids Res..

[14]  M. Ladanyi,et al.  Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone , 1997, Sarcoma.

[15]  M. Rosemann,et al.  MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. , 2012, Cancer genetics.

[16]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[17]  Min Liu,et al.  MicroRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1 , 2009, The FEBS journal.

[18]  W. Guo,et al.  MicroRNA‐9 up‐regulates E‐cadherin through inhibition of NF‐κB1–Snail1 pathway in melanoma , 2012, The Journal of pathology.

[19]  Tzong-Yi Lee,et al.  Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data , 2011, Nucleic acids research.

[20]  Jianzhi Zhang,et al.  Why Do Hubs Tend to Be Essential in Protein Networks? , 2006, PLoS genetics.

[21]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[22]  T. Luedde MicroRNA‐151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma , 2010, Hepatology.

[23]  Anne-Marie Cleton-Jansen,et al.  Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs , 2012, PloS one.

[24]  Gordon K. Smyth,et al.  A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..

[25]  Shuai Jiang,et al.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.

[26]  O. Hobert Gene Regulation by Transcription Factors and MicroRNAs , 2008, Science.

[27]  M. McCrae,et al.  Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex‐determining region Y box 6 in hepatocellular carcinoma , 2012, Cancer.

[28]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[29]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[30]  M. Rosemann,et al.  Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma , 2010, Clinical Cancer Research.

[31]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[32]  Jean Y. J. Wang,et al.  Targeting the RB-pathway in Cancer Therapy , 2010, Clinical Cancer Research.

[33]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[34]  Tsz-Kwong Man,et al.  Expression profiles of osteosarcoma that can predict response to chemotherapy. , 2005, Cancer research.

[35]  Matthieu Latapy,et al.  Computing Communities in Large Networks Using Random Walks , 2004, J. Graph Algorithms Appl..

[36]  J. Fei,et al.  miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML) , 2012, PloS one.

[37]  Holger Fröhlich,et al.  GOSim – an R-package for computation of information theoretic GO similarities between terms and gene products , 2007, BMC Bioinformatics.

[38]  T. Gilmore,et al.  Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.

[39]  S. Kaul,et al.  Viral Ski Inhibits Retinoblastoma Protein (Rb)-mediated Transcriptional Repression in a Dominant Negative Fashion* , 1999, The Journal of Biological Chemistry.

[40]  Nobuyoshi Shimizu,et al.  Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer. , 2008, Lung cancer.

[41]  L. Fajas,et al.  Metabolism and proliferation share common regulatory pathways in cancer cells , 2010, Oncogene.

[42]  Anton J. Enright,et al.  MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[43]  Mike Tyers,et al.  The GRID: The General Repository for Interaction Datasets , 2003, Genome Biology.

[44]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[45]  E. Trauwaert On the meaning of Dunn's partition coefficient for fuzzy clusters , 1988 .

[46]  Robert Gentleman,et al.  Using GOstats to test gene lists for GO term association , 2007, Bioinform..

[47]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[48]  Heng Zhang,et al.  Expression of miRNA-130a in Nonsmall Cell Lung Cancer , 2010, The American journal of the medical sciences.

[49]  M. Soares,et al.  Identification of Differentially Expressed MicroRNAs in Osteosarcoma , 2011, Sarcoma.

[50]  Ashley M. Jacobi,et al.  A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator , 2012, Proceedings of the National Academy of Sciences.

[51]  H. Zhang,et al.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. , 2010, Oncology reports.

[52]  Wei-Hua Wu,et al.  MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. , 2011, American journal of hypertension.

[53]  A. Statnikov,et al.  The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. , 2010, Cancer cell.

[54]  Yitzhak Pilpel,et al.  Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network , 2007, PLoS Comput. Biol..

[55]  Jia Chen,et al.  miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. , 2011, Biochemical and biophysical research communications.

[56]  E. Schwarz,et al.  Increased radiation‐induced apoptosis of Saos2 cells via inhibition of NFκB: A role for c‐Jun N‐terminal kinase , 2005, Journal of Cellular Biochemistry.

[57]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[58]  Zhaohui Gong,et al.  miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer , 2012, Journal of Cancer Research and Clinical Oncology.

[59]  Zhenfeng Duan,et al.  MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.

[60]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[61]  W. Winkelmann,et al.  Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas , 2002, International journal of cancer.

[62]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[63]  G. Delling,et al.  Studies of the RB1 gene and the p53 gene in human osteosarcomas. , 1992, Pediatric hematology and oncology.

[64]  B. H. Haug,et al.  MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. , 2011, Carcinogenesis.

[65]  Hua-Chien Chen,et al.  Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells , 2012, Nucleic acids research.

[66]  J. Squire,et al.  Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. , 2011, Cancer genetics.

[67]  R. DePinho,et al.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. , 2005, Genes & development.

[68]  M. Caligiuri,et al.  Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. , 2010, Cancer cell.

[69]  L. Xiaoyun,et al.  MicroRNA-21 is involved in osteosarcoma cell invasion and migration , 2011, Medical oncology.

[70]  Hao Ren,et al.  MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma , 2012, Carcinogenesis.

[71]  Michalis Vazirgiannis,et al.  Cluster validity methods: part I , 2002, SGMD.

[72]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[74]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[75]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[76]  Peter J. Rousseeuw,et al.  Finding Groups in Data: An Introduction to Cluster Analysis , 1990 .